EUVIMEDEUVIMED entdecken
Crossref

Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse

Weiming Liao, Zihan Wang, Han Wang, Yulin Zheng, Jie Wang, Yunzhe Li, Wei Wang, Xiaowei Wang, Liangren Zhang iD, Qi Sun iD, Zhuo Huang iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Weiming Liao und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Status Epilepticus, Receptors, GABA-A, Anticonvulsants, Thiazoles. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Status epilepticus (SE), a life-threatening neurological emergency, is primarily treated with benzodiazepines (BZDs), which act as positive allosteric modulators (PAMs) of γ2-containing GABAA receptors (GABAARs). However, their efficacy diminishes due to γ2 subunit internalization, leading to pharmaco-resistance. In this manuscript, a series of 2-(2-thienyl)-thiazolo[4,5-d]pyrimidin-7(6H)-one derivatives were designed and evaluated using two-electrode voltage clamp in Xenopus oocytes expressing α1β2 GABAARs. We identified (S)-9d as a potent α1β2γ2 subtype PAM, showing 13-fold potentiation at 10 μM (EC50: 0.9 μM in oocytes, 0.2 μM in CHO cells) as well as α1β2 (EC50 = 1.3 μM, 1700% enhancement, in oocytes). Molecular docking and mutagenesis revealed (S)-9d binds to a distinct β+/α- interface of α1β2 GABAARs. In SE mouse models, (S)-9d (5-30 mg/kg) significantly suppressed seizure progression and reduced delayed mortality, outperforming diazepam. This study establishes a promising strategy for refractory SE to overcome BZD limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusReceptors, GABA-AAnticonvulsantsThiazolesAnimalsMiceAllosteric RegulationMolecular Docking SimulationCHO CellsStructure-Activity RelationshipCricetulusOocytesXenopus laevisMaleProtein Subunits

Substanzen

Receptors, GABA-AAnticonvulsantsThiazolesProtein Subunits

Autor:innen und Institutionen

  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

ORCID-Profile: Liangren Zhang, Qi Sun, Zhuo Huang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liao, W., Wang, Z., Wang, H., Zheng, Y., Wang, J., Li, Y., Wang, W., Wang, X., Zhang, L., Sun, Q., & Huang, Z. (2025). Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00903

Vancouver

Liao W, Wang Z, Wang H, Zheng Y, Wang J, Li Y, et al. Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00903

BibTeX
@article{Liao2025,
  author = {Liao, Weiming and Wang, Zihan and Wang, Han and Zheng, Yulin and Wang, Jie and Li, Yunzhe and Wang, Wei and Wang, Xiaowei and Zhang, Liangren and Sun, Qi and Huang, Zhuo},
  title = {Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00903}
}
Kostenlos starten →